Axovant Sciences Ltd. (AXON)

1.17
0.07 5.60
NASDAQ : Health Technology
Prev Close 1.24
Open 1.25
Day Low/High 1.14 / 1.29
52 Wk Low/High 1.02 / 6.59
Volume 702.06K
Avg Volume 625.50K
Exchange NASDAQ
Shares Outstanding 122.28M
Market Cap 151.63M
EPS -2.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Axovant, Benetic Jump on Agreement to Develop Gene Therapy for MD

Axovant, Benetic Jump on Agreement to Develop Gene Therapy for MD

The deal is part of Axovant's strategy to focus on neurological gene therapies.

Okta, Celgene, Altria: 'Mad Money' Lightning Round

Okta, Celgene, Altria: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Okta, Celgene, GasLog Partners, Neutral Tandem, Altria, Axovant Sciences, Lowe's and more.

Tread Carefully: Cramer's 'Mad Money' Recap (Friday 6/15/18)

Tread Carefully: Cramer's 'Mad Money' Recap (Friday 6/15/18)

Jim Cramer says investors need to be cautious, as trade tensions are just one of the things causing markets to whiplash. But he's got your game plan for next week.

Axovant Sciences Reaches Analyst Target Price

Axovant Sciences Reaches Analyst Target Price

In recent trading, shares of Axovant Sciences Ltd have crossed above the average analyst 12-month target price of $4.60, changing hands for $4.80/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

These Stocks Are Leading the Nasdaq's Record-Setting Push

These Stocks Are Leading the Nasdaq's Record-Setting Push

The Nasdaq sets a record closing high for three straight sessions.

First Week Of June 15th Options Trading For Axovant Sciences (AXON)

Investors in Axovant Sciences Ltd saw new options become available this week, for the June 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AXON options chain for the new June 15th contracts and identified the following call contract of particular interest.

First Week of AXON November 16th Options Trading

Investors in Axovant Sciences Ltd saw new options become available this week, for the November 16th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 228 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

AXON INVESTOR ALERT: Law Offices Of Howard G. Smith Commences Investigation On Behalf Of Axovant Sciences Ltd. Investors

AXON INVESTOR ALERT: Law Offices Of Howard G. Smith Commences Investigation On Behalf Of Axovant Sciences Ltd. Investors

Law Offices of Howard G. Smith commences an investigation on behalf of Axovant Sciences Ltd.

Axovant Shares Crater as CEO and President Both Resign

Axovant Shares Crater as CEO and President Both Resign

Chief executive David Hung resigned from the Basel, Switzerland, biotech after just 10 months on the job.

Five Rules for This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)

Five Rules for This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)

Even with Monday's sharp reversal, Jim Cramer says he still likes this market.

Notable Monday Option Activity: AXON, AERI, PLAY

Notable Monday Option Activity: AXON, AERI, PLAY

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Axovant Sciences Ltd , where a total volume of 10,433 contracts has been traded thus far today, a contract volume which is representative of approximately 1.0 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 84.2% of AXON's average daily trading volume over the past month, of 1.2 million shares.

Commit To Buy Axovant Sciences At $5, Earn 69.1% Annualized Using Options

Commit To Buy Axovant Sciences At $5, Earn 69.1% Annualized Using Options

Investors considering a purchase of Axovant Sciences Ltd stock, but cautious about paying the going market price of $5.06/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May 2018 put at the $5 strike, which has a bid at the time of this writing of $1.40.

Where Softbank Founder Masayoshi Son Is Placing Big Bets

Where Softbank Founder Masayoshi Son Is Placing Big Bets

Softbank founder Masayoshi Son is placing big bets on artificial intelligence applications from chips to cars to workplace chats. He'll likely need more than one $100 billion fund to do it.

Axovant Rises After Tuesday's Plunge - Biotech Movers

Axovant Rises After Tuesday's Plunge - Biotech Movers

Axovant shares were up in premarket trading on Sept. 27 after plummeting on Tuesday on the heels of the announcement that the company's Phase 3 study of intepirdine in patients with Alzheimer's disease did not achieve its co-primary efficacy endpoints.

Axovant Shares Plummet On Alzheimer's Data; Genocea Gets Rocked -Biotech Movers

Axovant Shares Plummet On Alzheimer's Data; Genocea Gets Rocked -Biotech Movers

The company said Tuesday its Phase 3 study of intepirdine in patients with Alzheimer's disease did not achieve its co-primary efficacy endpoints.Meanwhile, shares of Genocea Biosciences Inc. were down, after the Cambridge, Mass.-based company announced a shift to immuno-oncology and a focus on developing neoantigen cancer vaccines.

Stocks Largely Hold on to Gains Following Yellen's Speech

Stocks Largely Hold on to Gains Following Yellen's Speech

Carnival shares jump after beating quarterly estimates but Adidas stock slumped following an investigation into a NCAA Bribery Scandal.

Stocks Rise as Fed's Yellen Walks the Line on Future Rate Hikes

Stocks Rise as Fed's Yellen Walks the Line on Future Rate Hikes

Stocks are higher. Here's how the market is trading in the afternoon session on Tuesday.

Axovant Sciences is Now Oversold (AXON)

Axovant Sciences is Now Oversold (AXON)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Notable Monday Option Activity: AXON, OA, AST

Notable Monday Option Activity: AXON, OA, AST

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Axovant Sciences Ltd , where a total volume of 43,808 contracts has been traded thus far today, a contract volume which is representative of approximately 4.4 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 624.2% of AXON's average daily trading volume over the past month, of 701,830 shares.

These Are the Best Growth Stocks Right Now in Biotech

These Are the Best Growth Stocks Right Now in Biotech

Top names.

Shark Bites: You Don't Want to Play the Gambler Today

Shark Bites: You Don't Want to Play the Gambler Today

This is one of those days when it may pay to walk away.

Wake Me When The Market Regains a Pulse

Wake Me When The Market Regains a Pulse

Biotechnology is showing little relative strength and oil is up again, but there isn't much going on with themes.

Biotech Movers: OncoMed Tanks After Barrage of Bad News, Akorn Rises on Deal Talk

Biotech Movers: OncoMed Tanks After Barrage of Bad News, Akorn Rises on Deal Talk

OncoMed Pharmaceuticals, Geron and Akorn were among the biotech stock movers in premarket trading on Monday.